BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 27598811)

  • 1. Oxygen and Perfusion Kinetics in Response to Fractionated Radiation Therapy in FaDu Head and Neck Cancer Xenografts Are Related to Treatment Outcome.
    Hu F; Vishwanath K; Salama JK; Erkanli A; Peterson B; Oleson JR; Lee WT; Brizel DM; Ramanujam N; Dewhirst MW
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):462-469. PubMed ID: 27598811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Pulsed Radiation Therapy on Tumor Oxygenation in 2 Murine Models of Head and Neck Squamous Cell Carcinoma.
    Wobb J; Krueger SA; Kane JL; Galoforo S; Grills IS; Wilson GD; Marples B
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):820-8. PubMed ID: 26104936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in tumor oxygenation during combined treatment with split-course radiotherapy and chemotherapy in patients with head and neck cancer.
    Stadler P; Feldmann HJ; Creighton C; Kau R; Molls M
    Radiother Oncol; 1998 Aug; 48(2):157-64. PubMed ID: 9783887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsed Radiation Therapy With Concurrent Cisplatin Results in Superior Tumor Growth Delay in a Head and Neck Squamous Cell Carcinoma Murine Model.
    Meyer K; Krueger SA; Kane JL; Wilson TG; Hanna A; Dabjan M; Hege KM; Wilson GD; Grills I; Marples B
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):161-9. PubMed ID: 27511853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation.
    Petersen C; Zips D; Krause M; Schöne K; Eicheler W; Hoinkis C; Thames HD; Baumann M
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):483-93. PubMed ID: 11567825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the fraction of total hypoxia and hypoxia subtypes in human squamous cell carcinomas upon fractionated irradiation: evaluation using pattern recognition in microcirculatory supply units.
    Maftei CA; Bayer C; Shi K; Astner ST; Vaupel P
    Radiother Oncol; 2011 Oct; 101(1):209-16. PubMed ID: 21641070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stochastic Predictions of Cell Kill During Stereotactic Ablative Radiation Therapy: Do Hypoxia and Reoxygenation Really Matter?
    Harriss-Phillips WM; Bezak E; Potter A
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1290-7. PubMed ID: 27212197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET for detecting tumor repopulation during fractionated radiotherapy of human FaDu squamous cell carcinoma in nude mice.
    Yue JB; Yang J; Liu J; Lee J; Cabrera AR; Sun XD; Bai GH; Li YH; Yu JM
    Radiother Oncol; 2014 Jun; 111(3):475-81. PubMed ID: 24813091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of reoxygenation during fractionated radiotherapy in head and neck squamous cell carcinoma xenografts.
    Harriss W; Bezak E; Yeoh E; Hermans M
    Australas Phys Eng Sci Med; 2010 Sep; 33(3):251-63. PubMed ID: 20878297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive diffuse optical measurement of blood flow and blood oxygenation for monitoring radiation therapy in patients with head and neck tumors: a pilot study.
    Sunar U; Quon H; Durduran T; Zhang J; Du J; Zhou C; Yu G; Choe R; Kilger A; Lustig R; Loevner L; Nioka S; Chance B; Yodh AG
    J Biomed Opt; 2006; 11(6):064021. PubMed ID: 17212544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma--a prospective study.
    Hoff CM; Grau C; Overgaard J
    Radiother Oncol; 2012 Apr; 103(1):38-44. PubMed ID: 22385797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linear-quadratic analysis of tumour response to fractionated radiotherapy: a study on human squamous cell carcinoma xenografts.
    Petersen C; Baumann M; Dubben HH; Arps H; Melenkeit A; Helfrich J
    Int J Radiat Biol; 1998 Feb; 73(2):197-205. PubMed ID: 9489567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of [(18)F]FMISO stratified dose-escalation on local control in FaDu hSCC in nude mice.
    Schütze C; Bergmann R; Brüchner K; Mosch B; Yaromina A; Zips D; Hessel F; Krause M; Thames H; Kotzerke J; Steinbach J; Baumann M; Beuthien-Baumann B
    Radiother Oncol; 2014 Apr; 111(1):81-7. PubMed ID: 24636842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of pre- and early per-treatment FDG-PET based dose-escalation on local tumour control in fractionated irradiated FaDu xenograft tumours.
    Jentsch C; Bergmann R; Brüchner K; Mosch B; Yaromina A; Krause M; Zips D; Troost EGC; Löck S; Kotzerke J; Steinbach J; Thames H; Baumann M; Beuthien-Baumann B
    Radiother Oncol; 2016 Dec; 121(3):447-452. PubMed ID: 27544820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation and micromilieu during fractionated irradiation of human FaDu squamous cell carcinoma in nude mice.
    Petersen C; Eicheler W; Frömmel A; Krause M; Balschukat S; Zips D; Baumann M
    Int J Radiat Biol; 2003 Jul; 79(7):469-77. PubMed ID: 14530154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of xenografts of human malignant gliomas and squamous cell carcinomas to fractionated irradiation.
    Baumann M; DuBois W; Pu A; Freeman J; Suit HD
    Int J Radiat Oncol Biol Phys; 1992; 23(4):803-9. PubMed ID: 1319979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of heat shock protein 70 as a tumor-specific biomarker for monitoring the outcome of radiation therapy in tumor mouse models.
    Bayer C; Liebhardt ME; Schmid TE; Trajkovic-Arsic M; Hube K; Specht HM; Schilling D; Gehrmann M; Stangl S; Siveke JT; Wilkens JJ; Multhoff G
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):694-700. PubMed ID: 24521683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.